Tryptophan and brain disorders

44 ta ish

1. Morpho functional changes in thymus of white rats in acute stress

   Dilnoza Ahrorovna Khasanova, Nigora Khamroevna Asadova

   MaqolaStress Responses and CortisolACADEMICIA An International Multidisciplinary Research Journal20215 iqtibos

   ABIABI:AkademIndex/2021.article.001087

2. Natural Neurotropic Autoantibodies in Blood Serum of Epilepsy Patients

   Kh. A. Rasulova, R.B. Azizova

   MaqolaOAOchiq kirishAutoimmune Neurological Disorders and TreatmentsAnnals of the Russian academy of medical sciences20142 iqtibos

   ABIABI:AkademIndex/2014.article.000124

3. Synthesis and Antidepressant Activity of 5-(2-Aminophenyl)-1,3,4-Oxadiazole-2-(3H)-Thione

   Zafar Isomiddinovich Sanoev, Sokhib Zamon O’gli Rashidov, Tolmas Tolibovich Khamroev +5

   MaqolaOAOchiq kirishNeurotransmitter Receptor Influence on BehaviorBiomedical & Pharmacology Journal20262 iqtibos

   ABIABI:AkademIndex/2026.article.010060

4. The emerging role of microbiota-derived short-chain fatty acids in immunometabolism

   Saade Abdalkareem Jasim, Maria Jade Catalan Opulencia, Andrés Alexis Ramírez‐Coronel +9

   Sharh maqolaGut microbiota and healthInternational Immunopharmacology20221 iqtibos

   ABIABI:AkademIndex/2022.review-article.000010

5. Synthesis and peculiarities of the distribution of a new14C-labeled immunodepressive compound in mice

   U. A. Aripov, A. D. Sakhibov, B. Z. Kasymov +4

   MaqolaChemical Reactions and IsotopesPharmaceutical Chemistry Journal19830 iqtibos

   ABIABI:AkademIndex/1983.article.000123

6. Anxiogenic activity of quinolinic acid and kynurenine in the social interaction test in mice

   Izyaslav P. Lapin, Ludmila G. Mutovkina, Ivan V. Ryzov +1

   MaqolaTryptophan and brain disordersJournal of Psychopharmacology19960 iqtibos

   ABIABI:AkademIndex/1996.article.000009

7. Comparison of the efficacy and safety of moclobemide and imipramine in the treatment of depression in Indian patients

   Ajit Avasthi, Parmanand Kulhara, Gagandeep Singh +2

   MaqolaOAOchiq kirishTreatment of Major DepressionIndian Journal of Psychiatry20050 iqtibos

   ABIABI:AkademIndex/2005.article.000191

8. Evaluation of lipoperoxidation processus of HIV‐infected patients

   Zebiniso P Rakhmanova

   MaqolaBiochemical Acid Research StudiesThe FASEB Journal20080 iqtibos

   ABIABI:AkademIndex/2008.article.000485

9. Polymorphisms of genes of oxidative stress and glutamate excitotoxicity in patients with tardive dyskinesia in schizophrenia

   Nodir Nurmetov, Oybek Kurbanov, Zarifboy Ibodullaev +1

   MaqolaTryptophan and brain disordersParkinsonism & Related Disorders20150 iqtibos

   ABIABI:AkademIndex/2015.article.000398

10. Optimization of therapy clinic-immunological disorders with heroin addiction

    N. Khodjaeva, S. Sultanov

    MaqolaOAOchiq kirishTryptophan and brain disordersEuropean Psychiatry20160 iqtibos

    ABIABI:AkademIndex/2016.article.000587

11. Treatment of patients with opioid addiction with different disease duration

    N. Khodjaeva, S. Sultanov

    MaqolaOAOchiq kirishNeurological Disorders and TreatmentsEuropean Psychiatry20160 iqtibos

    ABIABI:AkademIndex/2016.article.000595

12. Immunoreactivity of neurotropic autoantibodies and neurotransmitters in the pathogenesis of symptomatic and idiopathic epilepsy

    D. Akramova

    MaqolaChemical Reactions and IsotopesJournal of the Neurological Sciences20170 iqtibos

    ABIABI:AkademIndex/2017.article.000466

13. Role of the Immunological Markers in the Pathogenesis of Symptomatic Epilepsy in Children

    Aliye Khalilova, Yokudhon N. Madjidova, Adolat Ismailova

    MaqolaOAOchiq kirishTryptophan and brain disordersInternational Journal of Biomedicine20170 iqtibos

    ABIABI:AkademIndex/2017.article.000864

14. New characteristics of neurophysiological changes in neurocognitive disorders in HIV-infected patients in Uzbekistan

    А. И. Сабирова, S. Kuranbaeva, G. Rakhimbaeva

    MaqolaOAOchiq kirishHIV Research and TreatmentJournal of the Neurological Sciences20190 iqtibos

    ABIABI:AkademIndex/2019.article.001623

15. COVID-19: well-known drugs, new opportunities

    Uzbekistan’s Public Healthcare Ministry, 26 Spitamena Str., Tashkent, 100121, Uzbekistan, А Х Аширметов, I.R. Mavlyanov +2

    MaqolaVitamin C and Antioxidants ResearchHealth risk analysis20200 iqtibos

    ABIABI:AkademIndex/2020.article.000769

16. Features of minor depressive disorder subtypes in conditions of COVID-19 pandemic

    S. Sultanov, Nazira Khodzhaeva, Zarifjon Ashurov +2

    MaqolaOAOchiq kirishCOVID-19 and Mental HealthIndian Journal of Psychiatry20200 iqtibos

    ABIABI:AkademIndex/2020.article.001771

17. Immune mechanisms of depressive disorders in parkinson's disease

    S. Shokhimardonv

    MaqolaTryptophan and brain disordersParkinsonism & Related Disorders20200 iqtibos

    ABIABI:AkademIndex/2020.article.004038

18. Clinical and pathogenetic structure of neuropsychological syndromes in COVID-19 depending on gender differences

    Khodjiyeva Dilbar Tadjiyevna, Safarov Komiljon Kamolovich

    MaqolaLong-Term Effects of COVID-19Web of Scientist: International Scientific Research Journal20210 iqtibos

    ABIABI:AkademIndex/2021.article.004187

19. The level of carbonylation of plasma proteins and peripheral blood leukocytes in patients with different duration of Alzheimer’s disease

    Petrov Dmitriy Sergeevich Petrov Dmitriy Sergeevich, Mariya Engalycheva, N.V. Korotkova +1

    MaqolaBiochemical effects in animalsVestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery)20210 iqtibos

    ABIABI:AkademIndex/2021.article.007328

20. Clinical and genetic associations of the CLOCK circadian rhythm gene and depressive disorders in patients with alcohol dependence syndrome during the period of alcohol abstinence

    N. R. Tulbaeva, Р. Ф. Насырова, Daria Smirnova +5

    MaqolaOAOchiq kirishCircadian rhythm and melatoninNeurology neuropsychiatry Psychosomatics20220 iqtibos

    ABIABI:AkademIndex/2022.article.008418

21. SARATONGA QARSHI 1,2,3-TRIAZOL-SAQLAGAN BIRIKMALAR

    Anvarjon Yusuf o’g’li Buronov, Zarifa Isakulovna Murtazayeva, Davlat Bobomurodovich Tuxtayev +3

    MaqolaOAOchiq kirishChemical Reactions and IsotopesJournal of Chemistry of Goods and Traditional Medicine20230 iqtibos

    ABIABI:AkademIndex/2023.article.009181

22. Novel Therapeutic Targets for Treating Alzheimer’s Disease

    Magham Sai Varshini, Ammu V. V. V. Ravi Kiran, Kusuma Kumari Garikapati +3

    BobAlzheimer's disease research and treatments20230 iqtibos

    ABIABI:AkademIndex/2023.chapter.000158

23. Immunological and neuroanatomic markers of the clinical dynamics of MCI and pre-MCI

    И К Малашенкова, Sergey Krynskiy, Daniil Ogurtsov +13

    MaqolaTryptophan and brain disordersS S Korsakov Journal of Neurology and Psychiatry20240 iqtibos

    ABIABI:AkademIndex/2024.article.002431

24. ИНТЕГРАТИВНЫЙ ПОДХОД К ПОНИМАНИЮ ПРИЧИН ДЕПРЕССИИ: ВЗАИМОДЕЙСТВИЕ ГЕНЕТИЧЕСКИХ, БИОЛОГИЧЕСКИХ, ПСИХОЛОГИЧЕСКИХ И СОЦИОКУЛЬТУРНЫХ ФАКТОРОВ

    Робия Абдуразакова

    MaqolaOAOchiq kirishStress Responses and CortisolMedical science of Uzbekistan20240 iqtibos

    ABIABI:AkademIndex/2024.article.005996

25. A comprehensive review of the intersection between asthma and depression

    Tahoora Abdul Nasir Surve, D. Sharma, Kiyan Ghani Khan +7

    Sharh maqolaAsthma and respiratory diseasesJournal of Asthma20240 iqtibos

    ABIABI:AkademIndex/2024.review-article.000055